Clinical TrialsSearch results
Number of results: 498
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Evaluation of conjunctival hyperemia in switching from Lipasudil to Lipasudil Brimonidine
- primary open-angle glaucoma
- Kazuyuki Hirooka
- 2024-09-03
Other
- R-MPV-R-A EGA trial
- Primary central nervous system lymphoma
- Yamasaki Fumiyuki
- 2019-03-22
Recruiting
- iStent inject with cataract surgery for primary angle closure glaucoma
- Primary angle closure glaucoma
- Hirooka Kazuyuki
- 2023-04-24
Completed
- Phase 3 Randomized, Double- Blind,Placebo Controlled, MulticenterStudy to Compare the Efficacy and Safety of Lenalidomide(CC-5013) PlusR- CHOP Chemotherapy (R2-CHOP)Versus Placebo Plus R- CHOP Chemotherapy in Subjects with Previously UntreatedActivated B- cell Type Diffuse Large B- cell Lymphoma
- Previously untreated, activated B-cell (ABC) type diffuse large B- cell lymphoma
- Hayakawa Jin
- 2023-03-02
Other
- Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-05-04
Other
- Lung Cancer Evaluation of TS-1 Study
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-10-18
Other
- A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer
- previously untreated elderly non-small cell lung cancer
- West Japan Oncology Group
- 2005-08-22
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Phase III Randomized Study of Imatinib therapy in chornic phase chronic myeloid leukemia comparing standard dose-escalation with progressive dose-escalation (JALSG CML207study)
- Previously untreated Chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2007-09-15
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11